CAS
NO |
4697-14-7,
34787-01-4 (parent) 74682-62-5 (disodium
salt) |
|
EINECS
NO. |
252-213-5 |
FORMULA |
C15H14N2Na2O6S2 |
MOL
WT. |
428.38 |
H.S.
CODE
|
|
TOXICITY
|
|
SYNONYMS |
Ticarcilina; Ticarcilline; Ticarcillinum; |
N-(2-Carboxy-3,3-dimethyl -7-oxo-4-thia-1-azabicyclo[3.2.0] hept-6-yl)-3-thio-
phenemalonamic acid;
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic
acid, 6- ((carboxy-3-thienylacetyl)amino)- 3,3- dimethyl-7-oxo-,
(2S-(2alpha,5alpha,6beta(S')))-; 6-((Carboxy-3-thienylacetyl)amino)-3,3-
dimethyl-7-oxo-4-
thia-1-azabicyclo(3.2.0) heptane-2-carboxylic acid. |
DERIVATION |
|
CLASSIFICATION
|
|
PHYSICAL
AND CHEMICAL PROPERTIES
|
PHYSICAL
STATE |
white to off-white crystalline
powder |
MELTING
POINT |
|
BOILING
POINT |
|
SPECIFIC
GRAVITY |
|
SOLUBILITY
IN WATER |
|
pH |
6
- 8 |
VAPOR
DENSITY |
|
REFRACTIVE
INDEX
|
|
NFPA
RATINGS
|
|
AUTOIGNITION
|
|
FLASH
POINT |
|
STABILITY |
Stable
under ordinary conditions. |
APPLICATIONS
|
Ticarcillin is a semisynthetic broad-spectrum beta-lactam antibiotic effective against both
gram-negative and gram-positive organisms, derived from penicillin similar to carbenicillin in action. It is derived
from the basic penicillin nucleus, 6-amino-penicillanic acid. The chemical
designation is 6-((Carboxy-3-thienylacetyl) amino)-3,3- dimethyl-7-oxo-4-
thia-1-azabicyclo (3.2.0)heptane-2-carboxylic acid. It is used primarily in the treatment of
severe systemic infections, septicemia, and infections of the genitourinary
tract, the respiratory tract, or the soft tissues due to susceptible strains of
bacteria. It should be used only to treat infections by bacteria. It will not
treat viruses, including the flu. Ticarcillin is combined with potassium
clavulanate to maintain the effectiveness against resistance to beta-lactam
antibiotics. Ticarcillin disodium is administered intramuscularly or
intravenously.
Beta-lactamase enzymes are produced by some bacteria and have
resistance ability to beta-lactam antibiotics. These enzymes deactivate the
antibacterial properties of beta-lactam antibiotics by opening the beta-lactam
ring. Beta-lactamase inhibitors have little antimicrobial functions themselves
and are combined with an actual beta-lactam antibiotic. Beta-lactamase
inhibitors' function is to bind beta-lactamase enzymes to form an inactive
molecule so that the actual beta-lactam antibiotic access to the bacterial wall
which it destroys. Beta-lactamase inhibitors include clavulanic acid, sulbactam,
and tazobactam.
|
SALES
SPECIFICATION |
APPEARANCE
|
white to off-white crystalline
powder |
IDENTIFICATION
|
passed
|
ASSAY |
800 µg/mg (on the anhydrous basis)
min |
TICARCILLIN
CONTENT |
80.0 - 94.0 % (on the anhydrous basis) |
BACTERIAL ENDOTOXINS |
0.05 EU/mg max |
OPTICAL
ROTATION
|
+172º ~ +187º |
WATER
|
|
TRANSPORTATION |
PACKING |
5kgs
in drum
|
HAZARD
CLASS |
|
UN
NO. |
|
OTHER
INFORMATION |
|